Anxiety and Depression

April 26, 2018

Treating anxiety and depression with a longevity-promoting drug: Resveratrol, a longevity-promoting molecule derived from red grapes, ground nuts, wines and others, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down regulation of its target gene, 26/April/2018, 3.47 pm

Treating anxiety and depression with a longevity-promoting drug: Resveratrol, a longevity-promoting molecule derived from red grapes, ground nuts, wines and others, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down regulation of its target gene, 26/April/2018, 3.47 pm https://genomediscovery.org/wp-content/uploads/2018/04/Resveratrol-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/04/Resveratrol-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg April 26, 2018 June 5, 2018

Introduction: What they say: A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department of Stem Cell and Regenerative…

April 11, 2018

Bonding hormone-based therapy for anxiety and depression: Oxytocin, a peptide hormone and neuropeptide, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down regulation of its target gene, 11/April/2018, 11.04 pm

Bonding hormone-based therapy for anxiety and depression: Oxytocin, a peptide hormone and neuropeptide, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down regulation of its target gene, 11/April/2018, 11.04 pm https://genomediscovery.org/wp-content/uploads/2018/04/Oxytocin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/04/Oxytocin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg2_.jpg April 11, 2018 April 11, 2018

March 24, 2018

Molecular therapy for anxiety and depression: Tranilast, an anti-allergic medication, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 24/March/2018, 11.48 pm

Molecular therapy for anxiety and depression: Tranilast, an anti-allergic medication, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 24/March/2018, 11.48 pm https://genomediscovery.org/wp-content/uploads/2018/03/Tranilast-attenuates-anxiety-and-depression-through-upregulation-of-seratonin-receptors.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/03/Tranilast-attenuates-anxiety-and-depression-through-upregulation-of-seratonin-receptors.jpg March 24, 2018 March 24, 2018

March 20, 2018

Amino acid-based therapy for anxiety and depression: Tryptophan, an essential amino acid and precursor of the neurotransmitter serotonin and the sleeping hormone melatonin, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 20/March/2018, 10.06 pm

Amino acid-based therapy for anxiety and depression: Tryptophan, an essential amino acid and precursor of the neurotransmitter serotonin and the sleeping hormone melatonin, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 20/March/2018, 10.06 pm https://genomediscovery.org/wp-content/uploads/2018/03/Tryptophan-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/03/Tryptophan-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg March 20, 2018 March 20, 2018

March 8, 2018

Molecular therapy for anxiety and depression: Lactoferrin, a globular glycoprotein found in most of the biological fluids, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 8/March/2018, 6.10 am

Molecular therapy for anxiety and depression: Lactoferrin, a globular glycoprotein found in most of the biological fluids, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 8/March/2018, 6.10 am https://genomediscovery.org/wp-content/uploads/2018/03/Lactoferrin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/03/Lactoferrin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-levels-and-attenuates-anxiety-and-depression.jpg March 8, 2018 March 8, 2018

March 2, 2018

Polyamine-based therapy for anxiety and depression: Spermine, a natural polyamine, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 2/March/2018, 8.13 am

Polyamine-based therapy for anxiety and depression: Spermine, a natural polyamine, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 2/March/2018, 8.13 am https://genomediscovery.org/wp-content/uploads/2018/03/Spermine-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A-5-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/03/Spermine-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A-5-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg March 2, 2018 March 2, 2018

Polyamine-based therapy for anxiety and depression: Spermine, a natural polyamine, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 2/March/2018, 8.13 am

Popular Post